AU2001260291A1 - Combination of cerivastatin with ace inhibitors and the use thereof in medicaments - Google Patents

Combination of cerivastatin with ace inhibitors and the use thereof in medicaments

Info

Publication number
AU2001260291A1
AU2001260291A1 AU2001260291A AU6029101A AU2001260291A1 AU 2001260291 A1 AU2001260291 A1 AU 2001260291A1 AU 2001260291 A AU2001260291 A AU 2001260291A AU 6029101 A AU6029101 A AU 6029101A AU 2001260291 A1 AU2001260291 A1 AU 2001260291A1
Authority
AU
Australia
Prior art keywords
cerivastatin
medicaments
combination
ace inhibitors
ace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260291A
Other languages
English (en)
Inventor
Joachim Ippen
Gilbert Wagener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001260291A1 publication Critical patent/AU2001260291A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001260291A 2000-05-23 2001-05-10 Combination of cerivastatin with ace inhibitors and the use thereof in medicaments Abandoned AU2001260291A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025308 2000-05-23
DE10025308A DE10025308A1 (de) 2000-05-23 2000-05-23 Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln
PCT/EP2001/005350 WO2001089525A1 (fr) 2000-05-23 2001-05-10 Combinaison de cerivastatine et d'inhibiteurs de l'enzyme de conversion de l'angiotensine et son utilisation dans des medicaments

Publications (1)

Publication Number Publication Date
AU2001260291A1 true AU2001260291A1 (en) 2001-12-03

Family

ID=7643122

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260291A Abandoned AU2001260291A1 (en) 2000-05-23 2001-05-10 Combination of cerivastatin with ace inhibitors and the use thereof in medicaments

Country Status (3)

Country Link
AU (1) AU2001260291A1 (fr)
DE (1) DE10025308A1 (fr)
WO (1) WO2001089525A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003227691B2 (en) * 2002-05-03 2008-05-15 Hexal Ag Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
WO2004080488A2 (fr) * 2003-03-10 2004-09-23 Bayer Healthcare Ag Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
WO2001089525A1 (fr) 2001-11-29
DE10025308A1 (de) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
IL156678A0 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
EP1419785A4 (fr) Medicaments contenant un inhibiteur de la chymase et un inhibiteur de l'ace comme principes actifs
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU2002366201A1 (en) Use of defined copolymers as adjuvants and agents in the agrotechnical domain
EP1194150A4 (fr) Utilisation de nitroxydes dans la cicatrisation et la prevention des photodommages
AU7458201A (en) Laminate and use thereof
AU2001261750A1 (en) Laminate and its use
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU5680900A (en) Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments
AU5220800A (en) Combination of mtp inhibitors and lipid reducers and the use thereof in medicaments
AU2001260291A1 (en) Combination of cerivastatin with ace inhibitors and the use thereof in medicaments
AU5682900A (en) Combination of mtp inhibitors and active agents that influence the metabolism and use thereof in medicaments
AU2001262928A1 (en) Pharmaceutical compositions and their use
PL357906A1 (en) Combination of carboxyalkylethers with antihypertensives and pharmaceutical use